Abstract
Among U.S. high school students 2% identify as transgender. Adolescents (12-21 yo) with gender dysphoria may seek gender-affirming hormone therapy (GAHT). Previous studies have reported lower HDL among transgender youth before GAHT. The purpose of this study is to examine changes in lipids, glucose, blood pressure and BMI among transgender adolescents receiving GAHT for at least 2 years compared to baseline and normative values for adolescents.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
